Singapore: India pharmaceutical companies have yet again emerged as the biggest overseas sources of medicines sold in th...
Singapore: Simcere Pharma has agreed to sell its 99.99 percent stake in Jilin Boda Pharma for $65 million. The company f...
Singapore: Actavis has filed an abbreviated new drug application (ANDA) with the US FDA seeking approval to market Bupre...
Singapore: Global pharmaceutical company, Teva Pharmaceutical, is restructuring its management and organizational functi...
Singapore: Bayer pharmaceuticals announced changes in the top management, declaring Mr Dieter Weinand as the president o...
Mumbai: Indian drug giant Lupin Pharma has begun trial run at Mihan that it expects to become fully functional in two ye...
Bangalore:Â India-based Dr. Reddy's Laboratories has launched its montelukast sodium oral granules, a bioequivalent ge...
Singapore: Daiichi Sankyo's pharmaceuticals subsidiary, Daiichi Sankyo Espha is all set to launch five generic products ...
Bangalore: India-based Aurobindo Pharma has received final approval from the US Food & Drug Administration for Nevir...
Singapore: After reports of Indian drug majors Ranbaxy Laboratories, Aurobindo Pharma, Dr Reddy's Laboratories and Wockh...
Singapore: Mitsubishi Tanabe Pharma announced that the company has submitted an application for the manufacturing and ma...
Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generi...
Singapore: Mayne Pharma Group has announced the launch of Doxycycline Hyclate Delayed-Release tablet in the US through t...
Singapore: Medical Charity, Medecins Sans Frontieres (MSF) has condemned the US for mounting pressure on India's new gov...
Singapore: U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's Biologics License Application (BLA) for r...
Singapore: Novartis Pharmaceuticals has reported to settle its litigation with US subsidiary of India based Sun Pharmace...
Singapore: German drugmaker Bayer announced that Dr Marjin Dekkers will step down as the CEO, by the end of 2016. The fi...
Mumbai: Pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received final approval for its pregabalin capsules,...
Singapore: Tripura has become the first Indian state to announce its implementation of the country's health ministry's d...
Singapore: As a strong reaction to the import ban placed on Ranbaxy Laboratories' third manufacturing unit in India, the...
Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma...
Singapore: Soon after reports of Ranbaxy's Mohali manufacturing plant being issued a Form 483 by the US US FDA broke out...
Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecno...
Mumbai: Dr. Reddy's Laboratories, India's leading pharmaceutical company, recently launched Montelukast Sodium Tablets a...
Singapore:Â The South East Asian pharmaceuticals industry is forecast to witness a boost to $3.9 billion by 2016. The ...
